SkylineDx
Business Services · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lichtenauerlaan Brainpark Ii Building Xi...Phone Number
+31 107200310Website
www.skylinedx.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SkylineDx
Founded in 2005 and headquartered in The Netherlands, SkylineDx is a biotechnology company, focused on research and development of molecular diagnostics in oncology and inflammatory diseases.Explore more
SkylineDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SkylineDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when SkylineDx launches new products
Website visits: Recent activity has been detected on your website
Check if SkylineDx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if SkylineDx had a recent Job posting/layoffs
SkylineDx, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on SkylineDx recently announced quarterly report
Check out if SkylineDx is spiking on competitors!
Funding: Get notified immidiatlly once SkylineDx has new funding data
Congratulate Masked Content for being promoted to Masked Content at SkylineDx
Recommended Actions
Find VP level buyers at SkylineDx
Find 3 more new buyers
Company Profile Activity
Activity Insights
SkylineDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SkylineDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SkylineDx.
SkylineDx Tech Stack
A closer look at the technologies used by SkylineDx
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a mid-level source in accounting, has completed initiatives related to credit card billing within the last twelve months.
Accounting, Billing & Invoice, Financial Reporting, Consumer Finance, Finance
Project
, according to a mid-level source in accounting, has completed initiatives related to tax compliance within the last twelve months.
Accounting, Compliance, Financial Reporting, Finance, Tax
Project
Accounting, Financial Planning, Financial Reporting, Finance
SkylineDx News & Media
SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress
New gene-signature for cutaneous squamous cell carcinoma (CSCC) demonstrates ability to identify a subset of patients with higher risk of developing metastasis, outperforming existing staging systems ROTTERDAM, Netherlands and SAN DIEGO, April 23, 2026 /PRNewswire/ -- SkylineDx, an...Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
Peer-reviewed publication confirms Merlin CP-GEP¹ identifies a subset of T1a patients with SLN positivity above guideline thresholds Two Independent validations at Leading Academic Centers reported no high-risk T1a classifications in an Alternative GEP test SAN DIEGO and ROTTERDAM,...SkylineDx Launches a Guideline-Informed Risk Assessment Initiative to Support SLNB Decision-Making in Early-Stage Melanoma
The Initiative helps clinicians align their clinical practice with updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Melanoma (Version 1.2026) framework Provides T1b and T2a melanoma patients with a PREDICTIVE molecular test to assess individualized SLN metastasis...Merlin CP-GEP Becomes the First and Only Gene Expression Profile (GEP) Test Recommended by NCCN® Cutaneous Melanoma Guidelines to Assess Metastatic Risk
Merlin CP-GEP is the only molecular test recognized by NCCN as predictive and appropriate for use in select T1 and T2 patients to support shared decision-making regarding Sentinel Lymph Node Biopsy. NCCN guidelines highlight that patients identified as Merlin High Risk may have a...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SkylineDx
Sign Up For FreeTo access detailed company insights
Founded in 2005 and headquartered in The Netherlands, SkylineDx is a biotechnology company, focused on research and development of molecular diagnostics in oncology and inflammatory diseases.... Read More
